As of 3:59pm ET
| -0.14 / -6.36%|
The 7 analysts offering 12-month price forecasts for Novavax Inc have a median target of 12.00, with a high estimate of 25.00 and a low estimate of 1.00. The median estimate represents a +482.52% increase from the last price of 2.06.
The current consensus among 8 polled investment analysts is to Hold stock in Novavax Inc. This rating has held steady since September, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.